about
sameAs
Sex-based memory advantages and cognitive aging: a challenge to the cognitive reserve construct?Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive agingDepressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study.Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotesLongitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriersAPOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.Fibrillar amyloid correlates of preclinical cognitive decline.Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.Age, family history, and memory and future risk for cognitive impairment.Treatment of depression in patients with epilepsy.Patients with psychogenic nonepileptic seizures report more severe migraine than patients with epilepsy.Analysis of Minnesota Multiphasic Personality Inventory-2-Restructured Form response bias indicators as suppressors or moderators in a medical setting.Randomized comparison of the Personality Assessment Inventory and the Minnesota Multiphasic Personality Inventory-2 in the epilepsy monitoring unit.Initial development of Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) scales to identify patients with psychogenic nonepileptic seizures.Behavioral Interventions to Prevent or Delay Dementia: Protocol for a Randomized Comparative Effectiveness Study.Impact of Personality on Cognitive Aging: A Prospective Cohort Study.Role of theory of mind in emotional awareness and alexithymia: Implications for conceptualization and measurement.Quality of life in psychogenic nonepileptic seizures and epilepsy: the role of somatization and alexithymia.Relationship of indicators of neuropathology, psychopathology, and effort to neuropsychological results in patients with epilepsy or psychogenic non-epileptic seizures.Is donepezil effective for multiple sclerosis-related cognitive dysfunction? A critically appraised topic.The Minnesota Multiphasic Personality Inventory-2-Restructured Form in the epilepsy monitoring unitEstimating the diagnostic value of the trail making test for suboptimal effort in acquired brain injury rehabilitation patientsConfirming psychogenic nonepileptic seizures with video-EEG: sex mattersPsychometric properties of the MMPI-2-RF Somatic Complaints (RC1) scaleThe role of neuropsychology on an epilepsy monitoring unit: a peek behind the "do not disturb" sign
P50
Q27302017-4025B8BC-5758-4C6E-9BC7-ABB0C70C0ED3Q30469218-FEC6F925-A5A1-48B9-BEB1-B099F44A4020Q33899629-7BE52B0F-AD5E-46CB-924E-6E01346A7D1EQ34743183-92FD0355-4940-465A-87FA-3674057A2146Q34922644-3213E9BE-48BE-4DA7-BD72-3F00EF9E9BF2Q36090120-89D68C12-39D8-4338-9B24-8899D6E2323CQ37018071-F89E3101-9B07-4ED8-860B-2875904D22FCQ37319009-B22FDE54-CEC5-4C44-96B2-201A5AB27018Q37361162-AF239051-C2BA-4C5E-9ED8-3EC65ABDC80DQ37862629-4D05AC95-3878-456F-A6F4-531522459202Q40123736-C30BE6A7-39EF-4B56-A98C-6983C890B0B6Q41326122-8C02AC8D-9E94-4D01-B91F-09B2BEDA5F59Q44426120-F21DB146-AEB8-4277-8FD9-E861A6A98A2DQ45931008-1234D056-66A7-4BD2-AA42-35C98CCB48C3Q47163000-5A731792-A8E7-4858-9AAF-324D2372DFBBQ47714679-3E8D88F0-0EE2-41B6-8065-4E35419C011FQ47732591-F448B74F-DD65-4251-AD5A-0D99EC9D7D07Q48053873-B79A65EE-44BB-4BA0-B2B4-71B1249AE7EEQ50733469-AECA25CF-5AE1-4F0D-BC3B-B2140C7D4396Q50975014-2CEF4D62-CA5B-45D3-B9A6-07978407419BQ82448759-BC7A89BE-B73B-45F4-8ED0-0C6657451FD5Q82648102-14D149DA-E938-42C9-8D4C-53A324FD0A46Q83461544-7BCD95DD-2358-453C-BB05-13EDA75F26F5Q84992115-F084B530-D68E-48D7-AAE8-5742D0A5F155Q85886821-FC9BEC83-6A7C-4B72-8B59-534F53C4BED7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Dona E C Locke
@en
Dona E C Locke
@nl
type
label
Dona E C Locke
@en
Dona E C Locke
@nl
prefLabel
Dona E C Locke
@en
Dona E C Locke
@nl
P31
P496
0000-0002-1966-7716